COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
about
Stress-Related Immune Markers in Depression: Implications for TreatmentThe role of inflammation in schizophreniaBeyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive ReviewViral infection, inflammation and schizophreniaImmunological aspects of the treatment of depression and schizophrenia.UPLC-Tandem Mass Spectrometry Method for Simultaneous Determination of Fluoxetine, Risperidone, and Its Active Metabolite 9-Hydroxyrisperidone in Plasma: Application to Pharmacokinetics Study in Rats.S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond.Molecular profiles of parvalbumin-immunoreactive neurons in the superior temporal cortex in schizophrenia.Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?Somatic drugs for psychiatric diseases: aspirin or simvastatin for depression?Molecular Targets of Cannabidiol in Neurological DisordersAssociation of plasma ω-3 and ω-6 lipids with burden of disease measures in bipolar subjects.Cyclooxygenase-2 inhibition reduces stress-induced affective pathology.Ondansetron and simvastatin added to treatment as usual in patients with schizophrenia: study protocol for a randomized controlled trial.A review of antidepressant therapy in primary care: current practices and future directions.Immune system disturbances in schizophrenia.Early life stress and later peer distress on depressive behavior in adolescent female rats: Effects of a novel intervention on GABA and D2 receptors.Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development.Leonurine Exerts Antidepressant-Like Effects in the Chronic Mild Stress-Induced Depression Model in Mice by Inhibiting Neuroinflammation.Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations.
P2860
Q26771607-D1622BA8-5FC6-4931-809D-1C5C35473DE9Q26779719-732656F4-672A-41B4-9462-BFFDE235770FQ26782993-333110AB-3D02-4BB5-A9B9-06B0B574329EQ30440507-6D57C4E1-D8F5-4E6B-90A9-71CD981BC186Q33721031-669DD4F2-52BC-40D9-B228-2E78C6FC5647Q33800810-AB172D29-BE80-4EF7-973B-45C2E090FF0CQ34106243-5C0D6B86-21DF-4D76-AD15-EAD2E5333048Q35120498-C96F9E07-B783-47F0-B7B3-BB7C546213E8Q35225947-A1FBFB41-A37F-4E62-AF00-56274F746792Q36067322-A63ECB0F-F749-4A46-BC35-37974B5441BAQ36157649-617D26F5-2E19-4D5B-AC05-0724A0010268Q36390201-971FBC85-7B26-4F68-8B86-A4A5C8AC824BQ36888657-24FA24A1-1BCC-4C3D-8DEE-D089D07D2F49Q36924599-C444D68E-D719-4A6B-91A0-00A2B062962EQ37070398-25474DAF-4297-44E0-954F-420A8B279D8DQ37344544-3301716B-8FCF-4F71-881E-05CC500B8EF9Q38788702-BF1F2A3E-11A8-4BC8-A075-7D162AF2B150Q38974307-43EBAE95-F22C-45F8-8CBB-33645DDEA9B0Q47311360-3539BC1A-10BD-48DB-853E-2373E8EE0DA1Q54237101-8070FB86-6C03-4A18-8ACC-10ECF1787567
P2860
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
@ast
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
@en
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
@nl
type
label
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
@ast
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
@en
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
@nl
prefLabel
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
@ast
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
@en
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
@nl
P1476
COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
@en
P2093
Norbert Müller
P577
2010-01-01T00:00:00Z